{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:01:09Z","timestamp":1792764069310,"version":"4.5.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,9]],"date-time":"2013-08-09T00:00:00Z","timestamp":1376006400000},"content-version":"vor","delay-in-days":526,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.resinv.2012.02.001","type":"journal-article","created":{"date-parts":[[2012,3,30]],"date-time":"2012-03-30T03:03:32Z","timestamp":1333076612000},"page":"3-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":358,"title":["Utility of KL-6\/MUC1 in the clinical management of interstitial lung diseases"],"prefix":"10.1016","volume":"50","author":[{"given":"Nobuhisa","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuoki","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2012.02.001_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/ajrccm.161.2.ats3-00","article-title":"Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)","volume":"161","author":"American Thoracic Society","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2012.02.001_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","volume":"165","author":"American Thoracic Society","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2012.02.001_bib3","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2012.02.001_bib4","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1586\/epr.09.80","article-title":"Proteomic approaches for studying human parenchymal lung diseases","volume":"6","author":"Kinnula","year":"2009","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.resinv.2012.02.001_bib5","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1164\/rccm.200503-483OE","article-title":"Clinical advances in the diagnosis and therapy of the interstitial lung diseases","volume":"172","author":"King","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2012.02.001_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/1753465808096948","article-title":"Therapies for interstitial lung disease: past, present and future","volume":"2","author":"Kim","year":"2008","journal-title":"Ther Adv Respir Dis"},{"issue":"Suppl 1","key":"10.1016\/j.resinv.2012.02.001_bib7","first-page":"S1","article-title":"The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults","volume":"54","author":"British Thoracic Society recommendation","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2012.02.001_bib8","series-title":"The European Respiratory Monograph 46 Interstitial lung disease","first-page":"47","article-title":"The role of biomarkers in management of interstitial lung disease: implication of biomarkers derived from type II pneumocytes","author":"Nukiwa","year":"2009"},{"key":"10.1016\/j.resinv.2012.02.001_bib9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1465-9921-6-78","article-title":"Serum biomarkers in interstitial lung diseases","volume":"6","author":"Tzouvelekis","year":"2005","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2012.02.001_bib10","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1440-1843.2009.01600.x","article-title":"Non-invasive biomarkers in pulmonary fibrosis","volume":"14","author":"Prasse","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2012.02.001_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1465-9921-11-89","article-title":"Clinical use of biomarkers of survival in pulmonary fibrosis","volume":"11","author":"Thomeer","year":"2010","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2012.02.001_bib12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.pupt.2010.08.001","article-title":"Serum biomarkers in idiopathic pulmonary fibrosis","volume":"23","author":"van den Blink","year":"2010","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.resinv.2012.02.001_bib13","first-page":"85","article-title":"Predicting prognosis in idiopathic pulmonary fibrosis","volume":"27","author":"Barlo","year":"2010","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.resinv.2012.02.001_bib14","first-page":"203","article-title":"Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma","volume":"18","author":"Kohno","year":"1988","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.resinv.2012.02.001_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1378\/chest.96.1.68","article-title":"New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6.","volume":"96","author":"Kohno","year":"1989","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2012.02.001_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ijc.2910570717","article-title":"Difference in sero-diagnostic values among KL-6-associated mucins classified as cluster 9","volume":"8","author":"Kohno","year":"1994","journal-title":"Int J Cancer Suppl"},{"key":"10.1016\/j.resinv.2012.02.001_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ijc.2910570704","article-title":"Third International Workshop on Lung Tumor and Differentiation Antigens: overview of the results of the central data analysis","volume":"8","author":"Stahel","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1016\/j.resinv.2012.02.001_bib18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1165\/ajrcmb.17.4.2253","article-title":"KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts","volume":"17","author":"Hirasawa","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.resinv.2012.02.001_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/glycob\/cwr118","article-title":"Novel O-linked glycans containing 6'sulfo-Gal\/GalNAc of MUC1 secreted from human breast cancer YMBS cells: possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody","volume":"22","author":"Seko","year":"2012","journal-title":"Glycobiology"},{"key":"10.1016\/j.resinv.2012.02.001_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.tcb.2006.07.006","article-title":"Cell surface-associated mucins in signal transduction","volume":"16","author":"Singh","year":"2006","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.resinv.2012.02.001_bib21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.physiol.70.113006.100659","article-title":"Structure and function of the cell surface (tethered) mucins","volume":"70","author":"Hattrup","year":"2008","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.resinv.2012.02.001_bib22","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1074\/jbc.M208326200","article-title":"Tumor necrosis factor-alpha converting enzyme\/ADAM 17 mediates MUC1 shedding","volume":"278","author":"Thathiah","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2012.02.001_bib23","first-page":"2014","article-title":"Decreased MUC1 expression induces E-cadherin-mediated cell adhesion of breast cancer cell lines","volume":"58","author":"Kondo","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.resinv.2012.02.001_bib24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1349-7006.2006.00183.x","article-title":"Anti-tumor effect of the anti-KL-6\/MUC1 monoclonal antibody through exposure of surface molecules by MUC1 capping","volume":"97","author":"Doi","year":"2006","journal-title":"Cancer Sci"},{"key":"10.1016\/j.resinv.2012.02.001_bib25","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.bbrc.2005.10.144","article-title":"KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts","volume":"338","author":"Ohshimo","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.resinv.2012.02.001_bib26","first-page":"151","article-title":"Serum marker KL-6\/MUC1 for the diagnosis and management of interstitial pneumonitis","volume":"46","author":"Kohno","year":"1999","journal-title":"J Med Invest"},{"key":"10.1016\/j.resinv.2012.02.001_bib27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ijc.26007","article-title":"Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer","volume":"130","author":"Tanaka","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.resinv.2012.02.001_bib28","first-page":"107","article-title":"Expression and localization of MUC1, MUC2, MUC5AC and small intestinal mucin antigen in pancreatic tumors","volume":"24","author":"Yamasaki","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1016\/j.resinv.2012.02.001_bib29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s00795-007-0382-7","article-title":"Immunohistochemical and immunoelectron microscopic studies of the localization of KL-6 and epithelial membrane antigen (EMA) in presumably normal pulmonary tissue and in interstitial pneumonia","volume":"40","author":"Ohtsuki","year":"2007","journal-title":"Med Mol Morphol"},{"key":"10.1016\/j.resinv.2012.02.001_bib30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00795-007-0360-0","article-title":"Immunohistochemical distribution of SP-D, compared with that of SP-A and KL-6, in interstitial pneumonias","volume":"40","author":"Ohtsuki","year":"2007","journal-title":"Med Mol Morphol"},{"key":"10.1016\/j.resinv.2012.02.001_bib31","doi-asserted-by":"crossref","first-page":"806014","DOI":"10.1155\/2011\/806014","article-title":"A normal range of KL-6\/MUC1 independent of elevated SP-D indicates a better prognosis in the patients with honeycombing on high-resolution computed tomography","volume":"2011","author":"Hisata","year":"2011","journal-title":"Pulm Med"},{"key":"10.1016\/j.resinv.2012.02.001_bib32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000011969","article-title":"MUC1 expression in intramucosal colorectal neoplasms. Possible involvement in histogenesis and progression","volume":"56","author":"Tanimoto","year":"1999","journal-title":"Oncology"},{"key":"10.1016\/j.resinv.2012.02.001_bib33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000011868","article-title":"Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer","volume":"55","author":"Hiraga","year":"1998","journal-title":"Oncology"},{"key":"10.1016\/j.resinv.2012.02.001_bib34","first-page":"220","article-title":"Clinicopathology of sialomucin: MUC1, particularly KL-6 mucin, in gastrointestinal, hepatic and pancreatic cancers","volume":"3","author":"Inagaki","year":"2009","journal-title":"Biosci Trends"},{"key":"10.1016\/j.resinv.2012.02.001_bib35","first-page":"95","article-title":"Differential expression of the glycosylated forms of MUC1 during lung development","volume":"51","author":"Sakurai","year":"2007","journal-title":"Eur J Histochem"},{"key":"10.1016\/j.resinv.2012.02.001_bib36","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0954-6111(03)00124-0","article-title":"KL-6, a human MUC1 mucin, is expressed early in premature lung","volume":"97","author":"Sun","year":"2003","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2012.02.001_bib37","first-page":"639","article-title":"[Use of the ED046 kit to analyze serum KL-6 in patients with pneumonitis] [Article in Japanese]","volume":"34","author":"Kitamura","year":"1996","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"key":"10.1016\/j.resinv.2012.02.001_bib38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1378\/chest.102.1.117","article-title":"Circulating antigen KL-6 and lactate dehydrogenase for monitoring irradiated patients with lung cancer","volume":"102","author":"Kohno","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2012.02.001_bib39","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1378\/chest.101.3.858","article-title":"Monitoring of serum KL-6 antigen in a patient with radiation pneumonia","volume":"101","author":"Hamada","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2012.02.001_bib40","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1164\/ajrccm\/148.3.637","article-title":"KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease","volume":"148","author":"Kohno","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.resinv.2012.02.001_bib41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1378\/chest.108.2.311","article-title":"KL-6: a serum marker for interstitial pneumonia","volume":"108","author":"Kobayashi","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2012.02.001_bib42","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1378\/chest.109.5.1276","article-title":"Serum KL-6 for the evaluation of active pneumonitis in pulmonary sarcoidosis","volume":"109","author":"Kobayashi","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2012.02.001_bib43","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1164\/ajrccm.158.5.9803115","article-title":"Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis","volume":"158","author":"Yokoyama","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2012.02.001_bib44","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1164\/ajrccm.158.4.9712003","article-title":"Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis","volume":"158","author":"Takahashi","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2012.02.001_bib45","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2169\/internalmedicine.41.381","article-title":"Usefulness of the modified lavage technique of Bingisser and KL-6 monitoring in a patient with pulmonary alveolar proteinosis","volume":"41","author":"Ishikawa","year":"2002","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2012.02.001_bib46","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1164\/ajrccm.165.3.2107134","article-title":"Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases","volume":"165","author":"Ohnishi","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2012.02.001_bib47","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/thorax.58.10.872","article-title":"Circulating KL-6 levels in patients with drug induced pneumonitis","volume":"58","author":"Ohnishi","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2012.02.001_bib48","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1440-1843.2006.00834.x","article-title":"Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis","volume":"11","author":"Yokoyama","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2012.02.001_bib49","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2796.2008.01929.x","article-title":"Circulating KL-6\/MUC1 as an independent predictor for disseminated intravascular coagulation in acute respiratory distress syndrome","volume":"263","author":"Nakashima","year":"2008","journal-title":"J Intern Med"},{"key":"10.1016\/j.resinv.2012.02.001_bib50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1465-9921-12-32","article-title":"KL-6 concentration in pulmonary epithelial lining fluid is a useful prognostic indicator in patients with acute respiratory distress syndrome","volume":"12","author":"Kondo","year":"2011","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2012.02.001_bib51","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0962-8479(05)80010-3","article-title":"Evaluation of serum KL-6 levels in patients with pulmonary tuberculosis","volume":"76","author":"Inoue","year":"1995","journal-title":"Tuber Lung Dis"},{"key":"10.1016\/j.resinv.2012.02.001_bib52","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/ijc.23411","article-title":"Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors","volume":"122","author":"Ishikawa","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.resinv.2012.02.001_bib53","first-page":"4069","article-title":"Evaluation of serum KL-6, a mucin-like glycoprotein, as a tumor marker for breast cancer","volume":"6","author":"Ogawa","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.resinv.2012.02.001_bib54","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1002\/ijc.22613","article-title":"Circulating KL-6\/MUC1 mucin carrying sialyl Lewisa oligosaccharide is an independent prognostic factor in patients with lung adenocarcinoma","volume":"120","author":"Inata","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.resinv.2012.02.001_bib55","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/thorax.58.1.52","article-title":"High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia","volume":"58","author":"Ishii","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2012.02.001_bib56","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.rmed.2009.08.011","article-title":"Serum KL-6 in fibrotic NSIP: Correlations with physiologic and radiologic parameters","volume":"104","author":"Sakamoto","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2012.02.001_bib57","doi-asserted-by":"crossref","unstructured":"Ichiyasu H, Ichikado K, Yamashita A, et al. Pneumocyte biomarkers KL-6 and surfactant protein D reflect the distinct findings of high-resolution computed tomography in nonspecific interstitial pneumonia. Respiration 2012;83:190\u20137","DOI":"10.1159\/000326924"},{"key":"10.1016\/j.resinv.2012.02.001_bib58","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2796.2006.01704.x","article-title":"Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases","volume":"260","author":"Satoh","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.resinv.2012.02.001_bib59","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1183\/09031936.00152607","article-title":"Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement","volume":"33","author":"Antoniou","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2012.02.001_bib60","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/PL00007584","article-title":"Detection of interstitial pneumonitis in patients with rheumatoid arthritis by measuring circulating levels of KL-6, a human MUC1 mucin","volume":"175","author":"Oyama","year":"1997","journal-title":"Lung"},{"key":"10.1016\/j.resinv.2012.02.001_bib61","first-page":"1164","article-title":"KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases","volume":"27","author":"Nakajima","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.resinv.2012.02.001_bib62","first-page":"930","article-title":"Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis","volume":"27","author":"Yamane","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.resinv.2012.02.001_bib63","first-page":"429","article-title":"Longitudinal analysis of serum KL-6 levels in patients with systemic sclerosis: association with the activity of pulmonary fibrosis","volume":"21","author":"Yanaba","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.resinv.2012.02.001_bib64","first-page":"1112","article-title":"Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis","volume":"31","author":"Yanaba","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.resinv.2012.02.001_bib65","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1002\/art.21257","article-title":"Serum pulmonary and activation-regulated chemokine\/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis","volume":"52","author":"Kodera","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2012.02.001_bib66","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3899\/jrheum.080633","article-title":"Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma","volume":"36","author":"Hant","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.resinv.2012.02.001_bib67","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/ard.59.4.257","article-title":"Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis\/dermatomyositis","volume":"59","author":"Bandoh","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2012.02.001_bib68","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/rheumatology\/39.6.632","article-title":"Serum KL-6 in adult patients with polymyositis and dermatomyositis","volume":"39","author":"Kubo","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.resinv.2012.02.001_bib69","first-page":"27","article-title":"Surfactant protein D and KL-6 serum levels in systemic sclerosis: correlation with lung and systemic involvement","volume":"28","author":"Bonella","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.resinv.2012.02.001_bib70","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.resinv.2012.02.001_bib71","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1136\/ard.2009.126573","article-title":"Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA","volume":"69","author":"Nam","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2012.02.001_bib72","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2169\/internalmedicine.37.307","article-title":"KL-6 as a serologic indicator of Pneumocystis carinii pneumonia in immunocompromised hosts","volume":"37","author":"Hamada","year":"1998","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2012.02.001_bib73","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1378\/chest.06-1467","article-title":"Serum indicators for the diagnosis of Pneumocystis pneumonia","volume":"131","author":"Tasaka","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2012.02.001_bib74","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2334-9-47","article-title":"Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study","volume":"9","author":"Shimizu","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.resinv.2012.02.001_bib75","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2169\/internalmedicine.48.1680","article-title":"Clinical utility of serum beta-D-glucan and KL-6 levels in Pneumocystis jirovecii pneumonia","volume":"48","author":"Nakamura","year":"2009","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2012.02.001_bib76","doi-asserted-by":"crossref","first-page":"81s","DOI":"10.1183\/09031936.01.18s320081","article-title":"Hypersensitivity pneumonitis: current concepts","volume":"32","author":"Bourke","year":"2001","journal-title":"Eur Respir J Suppl"},{"key":"10.1016\/j.resinv.2012.02.001_bib77","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0091-6749(89)90349-7","article-title":"Guidelines for the clinical evaluation of hypersensitivity pneumonitis. Report of the Subcommittee on Hypersensitivity Pneumonitis","volume":"84","author":"Richerson","year":"1989","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.resinv.2012.02.001_bib78","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1378\/chest.118.2.445","article-title":"Serum KL-6 concentrations in dairy farmers","volume":"118","author":"Takahashi","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2012.02.001_bib79","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ajim.20380","article-title":"Therapeutic effects for hypersensitivity pneumonitis induced by Japanese mushroom (Bunashimeji)","volume":"49","author":"Tsushima","year":"2006","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.resinv.2012.02.001_bib80","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/ajim.20535","article-title":"Hypersensitivity pneumonitis caused by Penicillium citrinum, not Enoki spores","volume":"50","author":"Yoshikawa","year":"2007","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.resinv.2012.02.001_bib81","first-page":"141","article-title":"Chronic summer-type hypersensitivity pneumonitis: clinical similarities to idiopathic pulmonary fibrosis","volume":"24","author":"Inase","year":"2007","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.resinv.2012.02.001_bib82","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0169-5002(01)00215-X","article-title":"Serum levels of KL-6 are useful biomarkers for severe radiation pneumonitis","volume":"34","author":"Goto","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1016\/j.resinv.2012.02.001_bib83","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1378\/chest.125.1.340","article-title":"Serum levels of KL-6 for predicting the occurrence of radiation pneumonitis after stereotactic radiotherapy for lung tumors","volume":"125","author":"Hara","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2012.02.001_bib84","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1748-717X-5-32","article-title":"Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy","volume":"5","author":"Yamashita","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.resinv.2012.02.001_bib85","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1164\/rccm.200710-1501OC","article-title":"Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case\u2013control study","volume":"177","author":"Kudoh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2012.02.001_bib86","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1465-9921-12-97","article-title":"Change in serum KL-6 level from baseline is useful for predicting life-threatening EGFR-TKIs induced interstitial lung disease","volume":"12","author":"Kawase","year":"2011","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2012.02.001_bib87","doi-asserted-by":"crossref","first-page":"L1088","DOI":"10.1152\/ajplung.00420.2002","article-title":"Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome","volume":"286","author":"Ishizaka","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.resinv.2012.02.001_bib88","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1183\/09031936.03.00070303","article-title":"KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome","volume":"23","author":"Sato","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2012.02.001_bib89","doi-asserted-by":"crossref","first-page":"14430","DOI":"10.1016\/S0021-9258(17)36641-3","article-title":"Purification and characterization of sialyl-Le(a)-carrying mucins of human bile; evidence for the presence of MUC1 and MUC3 apoproteins","volume":"269","author":"Baeckstr\u00f6m","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2012.02.001_bib90","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1023\/A:1022208727512","article-title":"Tumor cell MUC1 and CD43 are glycosylated differently with sialyl-Lewis a and x epitopes and show variable interactions with E-selectin under physiological flow conditions","volume":"18","author":"Fernandez-Rodriguez","year":"2001","journal-title":"Glycoconj J"},{"key":"10.1016\/j.resinv.2012.02.001_bib91","doi-asserted-by":"crossref","first-page":"24198","DOI":"10.1074\/jbc.272.39.24198","article-title":"Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines","volume":"272","author":"Burdick","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2012.02.001_bib92","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1378\/chest.09-3082","article-title":"Mucins carrying selectin ligands as predictive biomarkers of disseminated intravascular coagulation complication in ARDS","volume":"139","author":"Nakashima","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2012.02.001_bib93","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","author":"Statement on sarcoidosis","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2012.02.001_bib94","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1378\/chest.124.6.2119","article-title":"Study of Clara cell 16, KL-6, and surfactant protein-D in serum as disease markers in pulmonary sarcoidosis","volume":"124","author":"Janssen","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2012.02.001_bib95","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1378\/chest.09-1975","article-title":"Comparative evaluation of serum markers in pulmonary sarcoidosis","volume":"137","author":"Miyoshi","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2012.02.001_bib96","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1164\/ajrccm.156.1.9612043","article-title":"Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis","volume":"156","author":"Inoue","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2012.02.001_bib97","first-page":"47","article-title":"Serum KL-6 as a novel disease marker in adolescent and adult cystic fibrosis","volume":"26","author":"Ohshimo","year":"2009","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.resinv.2012.02.001_bib98","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.healun.2011.07.010","article-title":"Comparison of serum KL-6 versus bronchoalveolar lavage neutrophilia for the diagnosis of bronchiolitis obliterans in lung transplantation","volume":"30","author":"Ohshimo","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.resinv.2012.02.001_bib99","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2466-11-22","article-title":"Ageing and long-term smoking affects KL-6 levels in the lung, induced sputum and plasma","volume":"11","author":"Ishikawa","year":"2011","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resinv.2012.02.001_bib100","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1165\/rcmb.2005-0151OC","article-title":"The mucin-1 568 adenosine to guanine polymorphism influences serum Krebs von den Lungen-6 levels","volume":"34","author":"Janssen","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.resinv.2012.02.001_bib101","first-page":"157","article-title":"Genetic studies on cystic fibrosis in Hawaii","volume":"20","author":"Wright","year":"1968","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.resinv.2012.02.001_bib102","first-page":"544","article-title":"The estimated incidence of cystic fibrosis in Japan","volume":"24","author":"Yamashiro","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534512000020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534512000020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:28:49Z","timestamp":1761949729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534512000020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S2212534512000020"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2012.02.001","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of KL-6\/MUC1 in the clinical management of interstitial lung diseases","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2012.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Japanese Respiratory Society. Published by Elsevier Japan KK","name":"copyright","label":"Copyright"}]}}